StockData

BioLargo, Inc. (BLGO) stock

BLGOOTCChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$0.07+0.00 (+0.90%)

Close on Oct 19, 2026Market cap $23.27MP/E –Yield –

BioLargo operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

BioLargo's operating cash flow for the twelve months ending Jun 30, 2026 was -$10.32M. For fiscal 2025 it was -$8.30M. The highest annual figure on record is -$1.21M in fiscal 2013.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$8.30M–
FY2024Dec 31, 2024-$3.21M–
FY2023Dec 31, 2023-$2.37M–
FY2022Dec 31, 2022-$2.76M–
FY2021Dec 31, 2021-$3.94M–
FY2020Dec 31, 2020-$4.15M–
FY2019Dec 31, 2019-$4.42M–
FY2018Dec 31, 2018-$3.89M–
FY2017Dec 31, 2017-$4.28M–
FY2016Dec 31, 2016-$3.72M–
FY2015Dec 31, 2015-$1.88M–
FY2014Dec 31, 2014-$1.72M–
FY2013Dec 31, 2013-$1.21M–
FY2012Dec 31, 2012-$2.03M–
FY2011Dec 31, 2011-$1.72M–
FY2010Dec 31, 2010-$1.30M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.06M–
Q1 FY2026Mar 31, 2026-$2.92M–
Q4 FY2025Dec 31, 2025-$1.59M–
Q3 FY2025Sep 30, 2025-$2.76M–
Q2 FY2025Jun 30, 2025-$2.12M–
Q1 FY2025Mar 31, 2025-$1.83M-480.5%
Q4 FY2024Dec 31, 2024-$1.92M–
Q3 FY2024Sep 30, 2024-$1.62M–
Q2 FY2024Jun 30, 2024-$151.00K–
Q1 FY2024Mar 31, 2024$481.00K–
Q4 FY2023Dec 31, 2023-$2.00K-104.9%
Q3 FY2023Sep 30, 2023-$836.00K–
Q2 FY2023Jun 30, 2023-$1.48M–
Q1 FY2023Mar 31, 2023-$43.00K–
Q4 FY2022Dec 31, 2022$41.00K–
Q3 FY2022Sep 30, 2022-$939.00K–
Q2 FY2022Jun 30, 2022-$724.00K–
Q1 FY2022Mar 31, 2022-$1.14M–
Q4 FY2021Dec 31, 2021-$975.00K–
Q3 FY2021Sep 30, 2021-$908.00K–
Q2 FY2021Jun 30, 2021-$1.21M–
Q1 FY2021Mar 31, 2021-$845.00K–
Q4 FY2020Dec 31, 2020-$836.00K–
Q3 FY2020Sep 30, 2020-$1.27M–
Q2 FY2020Jun 30, 2020-$1.29M–
Q1 FY2020Mar 31, 2020-$753.00K–
Q4 FY2019Dec 31, 2019-$1.24M–
Q3 FY2019Sep 30, 2019-$1.33M–
Q2 FY2019Jun 30, 2019-$982.00K–
Q1 FY2019Mar 31, 2019-$869.00K–
Q4 FY2018Dec 31, 2018-$840.00K–
Q3 FY2018Sep 30, 2018-$998.00K–
Q2 FY2018Jun 30, 2018-$1.06M–
Q1 FY2018Mar 31, 2018-$996.00K–
Q4 FY2017Dec 31, 2017-$1.21M–
Q3 FY2017Sep 30, 2017-$1.03M–
Q2 FY2017Jun 30, 2017-$872.38K–
Q1 FY2017Mar 31, 2017-$1.18M–
Q4 FY2016Dec 31, 2016-$921.82K–
Q3 FY2016Sep 30, 2016-$1.11M–

More BioLargo figures

See a number that looks wrong?